AstraZeneca plc, BP plc and Unilever plc are Brexit dividend WINNERS

AstraZeneca plc (LON: AZN), BP plc (LON: BP) and Unilever plc (LON: ULVR) are proving a handy foxhole amid a barrage of Brexit bad news, says Harvey Jones.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

Not every company stock collapsed in the aftermath of the shock Brexit referendum result, canny investors spotted opportunities as well as threats to their portfolio. As the pound collapsed, income seekers realised that companies with strong overseas earnings should prove more rewarding. Here are three stocks that are likely to be Brexit dividend winners.

Astra shines

Pharmaceuticals giant AstraZeneca (LSE: AZN) ended Friday 3.41% higher and is up 10.36% across the last turbulent week. Over the same period, sterling has fallen from around $1.46 to $1.33, a drop of around 9%. That is far from a coincidence. AstraZeneca generate more than 90% of its profits overseas but has a large cost base in the UK, which will be less of a burden as its overseas earnings rise relative to the pound.

AstraZeneca converts its dividends into pence on the day results are announced – twice a year in March and September – and although we don’t know whether the dollar will remain strong against sterling over the longer term, that’s certainly the way to bet right now. The company suffered during recent sterling strength, with Q1 results showing revenue up 5% to $6,115m, but just 1% at actual exchange rates. That now looks set to reverse. Trading at 13.3 times earnings it isn’t overpriced, while the yield is healthy at 4.9%. The big question is whether chief executive Pascal Soriot can replenish AstraZeneca’s drugs pipeline, but for now the dollar pipeline will be flowing.

Brexit petroleum

Friday’s result may have divided the nation but it united investors in pursuit of oil major BP (LSE: BP), whose share price rose 1.73% on the day and now stands nearly 6% higher than it did a week ago. In January, chief executive Bob Dudley warned that investment in the UK energy sector could fall if Britain voted to leave the EU. But the company put on a brave face after the result, publicly stating that “we do not currently expect it to have a significant impact on BP’s business or investments in the UK and continental Europe, nor on the location of our headquarters or our staff“. Investors are taking that at face value today.

The uncertainty has set back the oil price recovery, with Brent crude falling from over $50 to around $47 a barrel, but markets are calculating that this is only temporary. Sterling weakness is likely to last much longer and with oil priced in dollars BP’s revenues will be the beneficiary. As will income seekers, given that BP declares its dividend in dollars, and its current yield of 7.1% has just got even juicier.

Uni winner

Household goods giant Unilever (LSE: ULVR) is another instant Brexit winner rising 3.11% on the day and trading 6.72% higher over the week. Almost 60% of its revenues come from emerging markets, with dollar and euro earnings on top, which is good news when sterling is plunging against a basket of global currencies. 

Unilever reports in euros and UK investors have already benefitted from pre-referendum uncertainty: Unilever recently raised its Q1 dividend by 6% to EUR0.3201 per share, which equated to 17% in sterling terms. We can expect more of that, unless the euro comes under greater pressure as Brexit contagion spreads.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended Unilever. The Motley Fool UK has recommended AstraZeneca and BP. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A pastel colored growing graph with rising rocket.
Investing Articles

Here’s how long it’s taken £1k of Nvidia stock to turn into £10k today!

Our writer explains how money invested in Nvidia stock less than three years ago has grown in value over tenfold…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
US Stock

3 red flags I’m seeing right now for the S&P 500

Jon Smith points out some concerns he has with the S&P 500 at current levels and picks one stock he's…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

UK dividend shares are outperforming US tech stocks!

UK dividend shares aren’t just for passive income investors. Over the last 12 months, they’ve been outperforming their US tech…

Read more »

DIVIDEND YIELD text written on a notebook with chart
US Stock

Here’s how much passive income an investor could make with £2k in Meta stock

Jon Smith looks at Meta stock from a different angle to normal, considering it as an option for an investor's…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

1 of my top UK shares is up 15% in a day! Is it still a buy for me?

Celebrus shares are soaring after strong full-year results. At a P/E ratio below 13, is it one of the best…

Read more »

Close-up of children holding a planet at the beach
Investing Articles

£10,000 invested in Jet2 shares 2 years ago is now worth…

Jet2 shares have surged in recent months and finally appear to be pushing towards fair value. Dr James Fox shares…

Read more »

piggy bank, searching with binoculars
Investing Articles

This FTSE 100 blue-chip could rise 26% in 12 months, according to brokers

While this FTSE 100 dividend stock has put investors through the wringer in recent years, some analysts see brighter skies…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

A 3-step passive income strategy to target major wealth

Want to invest in the stock market to build up a passive income stream? There's no fiendlishly complex multi-step mystique…

Read more »